Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic

The World Health Organization (WHO), on March 11th 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19, and as of April, 14th 2020, there were over 5000 confirmed...

Full description

Saved in:
Bibliographic Details
Published in:Saudi journal of gastroenterology 2020-09, Vol.26 (5), p.233-239
Main Authors: Al-Judaibi, Bandar, Almaghrabi, Reem, Alghamdi, Mohammed, Al-Hamoudi, Waleed, AlQahtani, Mohammed, Abaalkhail, Faisal, Shagrani, Mohammed, Sanai, Faisal
Format: Article
Language:English
Subjects:
Betacoronavirus
cirrhosis
Comorbidity
Consensus
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Epidemics
Health aspects
Humans
Liver diseases
Liver Diseases - epidemiology
Liver Diseases - surgery
liver transplant
Liver transplantation
Liver Transplantation - methods
Liver transplants
Medical research
Pandemics
Pneumonia, Viral - epidemiology
SARS-CoV-2
Saudi Arabia - epidemiology
Severe acute respiratory syndrome coronavirus 2
Special Communication
Transplants & implants
Travel restrictions
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The World Health Organization (WHO), on March 11th 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19, and as of April, 14th 2020, there were over 5000 confirmed cases in Saudi Arabia (SA). Many countries, including SA, have imposed major restrictions on travel, and everyday life, and the implications of these necessary changes are being felt in liver transplant (LT) centers in SA. Concerns remain that there is an increased risk for individuals over 65 years of age, with underlying medical conditions, or for those who are immunocompromised. Therefore, the Saudi Association for the Study of Liver Diseases and Transplantation (SASLT) established an urgent task force to launch a statement that can be utilized by LT centers as a guidance in the management of patients with advanced liver disease from the time of LT listing to the post-operative care of transplanted patients.
ISSN:1319-3767
1998-4049
DOI:10.4103/sjg.SJG_131_20